Europe Pharmaceutical Stability and Storage Services Market Size, Share & Trends Analysis Report By Service Type (Stability, Storage), By Molecule Type (Small Molecule, Large Molecule) and By Country (U.K., Germany, France, Italy, Russia, Nordic, Benelux, Rest of Europe) Forecasts, 2026-2034

Last Updated: September 21, 2026 | Author: Dhanashri Chandgude | Format:

Europe Pharmaceutical Stability and Storage Services Market Size

The Europe Pharmaceutical Stability and Storage Services Market size was valued at USD 0.58 billion in 2025 and is projected to grow from USD 0.62 billion in 2026 to reach USD 1.11 billion by 2034, growing at a CAGR of 7.62% during the forecast period 2026–2034.

The pharmaceutical stability and storage services market has experienced substantial growth recently, driven by the expanding pharmaceutical industry's demand for reliable and efficient storage solutions. These services involve specialized facilities and expertise to maintain optimal conditions for pharmaceutical products, ensuring their quality and efficacy.

Regulatory compliance is a vital aspect of the European market, with agencies such as the European Medicines Agency (EMA) enforcing strict guidelines and standards for stability testing and storage to guarantee product safety, efficacy, and quality. Complying with these regulations is essential for obtaining marketing authorizations and maintaining market access within the European Union. Service providers in Europe play a crucial role in helping pharmaceutical companies meet these regulatory requirements through their expertise and specialized infrastructure.

Market Key Takeaways

Global Market Size & Growth

Storage dominated the market by services.

Large molecules dominate the market by molecules.

Outsourcing dominates the market by modes.

France dominates the market by region.

Europe Pharmaceutical Stability and Storage Services Market Size

Download a Free Sample To learn more about this report.

Services Insights

Storage dominated the market and is expected to register a CAGR of 6.9% over the forecast period.

Europe Pharmaceutical Stability and Storage Services Market Size By Segments

Request Customizationto receive a tailored report.

Molecules Insights

The Large molecules dominate the market and are expected to register a CAGR of 6.8% over the forecast period.

Modes Insights

The outsourcing market is expected to register a CAGR of 7.4% over the forecast period.

Europe Pharmaceutical Stability and Storage Services Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

The pharmaceutical stability and storage services market in Europe is a vibrant and varied sector within the pharmaceutical industry. Countries such as Germany, France, the United Kingdom, and Switzerland lead Europe, creating a robust stability and storage services market. These countries have well-established pharmaceutical industries, strict regulatory frameworks, and advanced healthcare systems, generating a need for dependable stability testing, storage solutions, and assistance with regulatory compliance across the region.

The pharmaceutical stability and storage services market in Europe is a significant and dynamic sector within the pharmaceutical industry. Europe has diverse countries with well-established healthcare systems, strong pharmaceutical manufacturing capabilities, and stringent regulatory frameworks, making it an important market for stability and storage services. One of the main drivers in Europe is the presence of a large pharmaceutical industry. Countries like Germany, France, the United Kingdom, and Switzerland have robust pharmaceutical sectors with a high concentration of companies, research institutions, and manufacturing facilities. These companies rely on reliable stability testing and storage services to ensure their pharmaceutical products' quality, stability, and regulatory compliance.

List of Key and Emerging Players in Europe Pharmaceutical Stability and Storage Services Market

Catalent Inc.

May BioServices

Almac Group

Charles River Laboratories International, Inc.

Alcami Corporation

PD Partners

Q Laboratories

Key Industry Developments

June 2026

Almac Group expanded its temperature-controlled stability storage capacity in Europe by investing in additional GMP-compliant storage chambers and analytical testing infrastructure for biopharmaceutical products.

May 2026

Eurofins Scientific expanded pharmaceutical stability testing capabilities through new laboratory infrastructure supporting ICH-compliant stability studies for biologics and small-molecule drugs across Europe.

March 2026

SGS expanded its pharmaceutical stability and storage services by increasing GMP-certified storage capacity and analytical testing capabilities for clinical and commercial drug products.

October 2025

WuXi AppTec expanded its European stability testing and cold-chain storage services, strengthening support for biologics, cell therapies, and advanced medicinal products.

Report Scope

Segmentation

By Service Type 2

Stability
Storage

By Molecule Type 2

Small Molecule
Large Molecule

Competitive Coverage Catalent Inc. · May BioServices · Almac Group · Charles River Laboratories International, Inc. · Alcami Corporation

Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The Europe pharmaceutical stability and storage services market size is projected to grow from USD 0.62 billion in 2026 to USD 1.11 billion by 2034, at a CAGR of 7.62% during the forecast period 2026-2034.

Demand for biopharmaceuticals and personalized medicine is one of the key trends in the Europe pharmaceutical stability and storage services market.

Rising demand for vaccines, increasing demand for biosimilars are the key drivers for the growth of the Europe pharmaceutical stability and storage services market.

Catalent Inc., May BioServices, Almac Group, Charles River Laboratories International, Inc., Alcami Corporation, PD Partners, Q Laboratories are the prominent players in the Europe pharmaceutical stability and storage services market.

About the Author

Dhanashri Chandgude

Senior Research Associate

Dhanashri Chandgude is a healthcare research professional with over four years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.

Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.